Literature DB >> 902460

Activation of monooxygenases in human liver by 7,8-benzoflavone.

J Kapitulnik, P J Poppers, M K Buening, J G Fortner, A H Conney.   

Abstract

Addition of 10(-4) M 7,8-benzoflavone to homogenates of human liver samples obtained by autopsy or surgical biopsy increased the rate of benzo[a]pyrene hydroxylation up to 11-fold. 7,8-Benzoflavone also increased the rates of hydroxylation of zoxazolamine and antipyrine at 10(-4) M but inhibited these reactions at 10(-6) M. The effects of 7,8-benzoflavone on the hydroxylation of benzo[a]pyrene and zoxazolamine in microsomes from human liver were similar to those in homogenates. Addition of 7,8-benzoflavone to homogenates of surgical biopsy samples of human liver had little or no effect on the rates of oxidative metabolism of 7-ethoxycoumarin, coumarin, and hexobarbital. Marked individuality for the activating and inhibiting effects of 7,8-benzoflavone was observed in different liver samples. This individuality may result both from the presence of multiple monooxygenases in varying amounts and proportions in the different liver samples and from a selective effect of 7,8-benzoflavone on certain of the monooxygenases.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 902460     DOI: 10.1002/cpt1977224475

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

2.  Possible enhancement of the first-pass metabolism of phenacetin by ingestion of grape juice in Chinese subjects.

Authors:  S Xiao Dong; Z Zhi Ping; W Zhong Xiao; C Chong Shu; C Fattore; G Gatti; S D'urso; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

3.  Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.

Authors:  D W Nebert
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-22

4.  Differential inhibition of biphenyl hydroxylation in perfused rat liver.

Authors:  G F Kahl; W Müller; R Kahl; H G Jonen; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

5.  Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.

Authors:  D Sesardic; A R Boobis; B P Murray; S Murray; J Segura; R de la Torre; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

6.  Cooperativity of cytochrome P450 1A2: interactions of 1,4-phenylene diisocyanide and 1-isopropoxy-4-nitrobenzene.

Authors:  Emre M Isin; Christal D Sohl; Robert L Eoff; F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2008-02-29       Impact factor: 4.013

7.  Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-488-H type cytochrome P-450.

Authors:  Y Yamazoe; M Abu-Zeid; K Yamauchi; R Kato
Journal:  Jpn J Cancer Res       Date:  1988-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.